A humanized, nondepleting anti-CD4 antibody that blocks virus entry inhibits virus replication in rhesus monkeys chronically infected with simian immunodeficiency virus

AIDS Research and Human Retroviruses

Volumn 18, Issue 11, 2002, Pages 747-755

  Reimann, Keith A ^a   Khunkhun, Rajinder ^a   Lin, Wenyu ^a   Gordon, Wayne ^b   Fung, Michael ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Tanox Biosystems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; MONOCLONAL ANTIBOBY HU5A8; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TREATMENT OUTCOME; VIREMIA; VIRUS INFECTION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CHRONIC DISEASE; HUMANS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0036343301     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260139486     Document Type: Article

References (18)

1. HIV entry and its inhibition
2. The HIV-1 envelope glycoproteins: Fusogens, antigens and immunogens
3. HIV-1 entry inhibitors in the side pocket
4. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
5. Single-dose safety, pharmacology and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
6. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody: Dissecting the basis for its inhibitory effect on HIV-induced cell fusion
7. In vivo administration in rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication
8. In vivo administration of CD4-specific monoclonal antibody: Effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques
9. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties
10. Development of anti-CD4 Mab hu5A8 for treatment of HIV-1 infection: Preclinical assessment in non-human primates
11. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus
12. Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus
13. High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates
14. HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells
15. Monoclonal antibodies to CD4
16. Anti-CD4 monoclonal antibodies in rheumatoid arthritis
17. Differential effects of administration of human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates
18. CD4-independent binding of SIV gp120 to rhesus CCR5